Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Financial Flexibility Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥118.65 Million (operating CF CN¥79.81 Million minus capex CN¥38.83 Million) represents 0% of total liabilities (CN¥1.42 Billion). Also explore how fast is Shandong Jincheng Pharmaceutical and Che growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 18 annual periods. Check Shandong Jincheng Pharmaceutical and Che (300233) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. For the full company profile including market capitalisation, see Shandong Jincheng Pharmaceutical and Che market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | CN¥420.52 Million | CN¥319.64 Million | CN¥1.47 Billion | ▲ +15.7% |
| 2024 | 0.25x | CN¥439.20 Million | CN¥296.59 Million | CN¥1.77 Billion | ▼ -47.5% |
| 2023 | 0.47x | CN¥1.01 Billion | CN¥664.08 Million | CN¥2.14 Billion | ▲ +62.4% |
| 2022 | 0.29x | CN¥629.29 Million | CN¥255.63 Million | CN¥2.17 Billion | ▼ -34.4% |
| 2021 | 0.44x | CN¥813.33 Million | CN¥437.19 Million | CN¥1.84 Billion | ▼ -17.0% |
| 2020 | 0.53x | CN¥818.56 Million | CN¥546.13 Million | CN¥1.53 Billion | ▼ -14.3% |
| 2019 | 0.62x | CN¥939.63 Million | CN¥577.98 Million | CN¥1.51 Billion | ▲ +6.4% |
| 2018 | 0.59x | CN¥702.08 Million | CN¥352.20 Million | CN¥1.20 Billion | ▲ +63.8% |
| 2017 | 0.36x | CN¥345.63 Million | CN¥151.83 Million | CN¥966.24 Million | ▼ -32.8% |
| 2016 | 0.53x | CN¥400.38 Million | CN¥241.48 Million | CN¥752.68 Million | ▼ -0.8% |
| 2015 | 0.54x | CN¥367.77 Million | CN¥207.92 Million | CN¥685.95 Million | ▼ -5.4% |
| 2014 | 0.57x | CN¥379.02 Million | CN¥219.46 Million | CN¥668.61 Million | ▲ +23.6% |
| 2013 | 0.46x | CN¥254.10 Million | CN¥93.92 Million | CN¥554.11 Million | ▲ +15.7% |
| 2012 | 0.40x | CN¥195.81 Million | CN¥86.61 Million | CN¥494.26 Million | ▼ -12.0% |
| 2011 | 0.45x | CN¥197.69 Million | CN¥62.69 Million | CN¥439.36 Million | ▲ +7.7% |
| 2010 | 0.42x | CN¥243.46 Million | CN¥108.67 Million | CN¥582.62 Million | ▼ -13.3% |
| 2009 | 0.48x | CN¥198.21 Million | CN¥105.62 Million | CN¥411.04 Million | ▲ +137.7% |
| 2008 | 0.20x | CN¥83.10 Million | CN¥30.23 Million | CN¥409.67 Million | — |